Inventors:
Suming Wang - Des Moines IA, US
Rodney Shackelford - Shreveport LA, US
International Classification:
A61K031/7048, A61K031/353, A61K031/198, A61K031/195
US Classification:
514027000, 514456000, 514566000
Abstract:
This invention relates to the methods and pharmaceutical compositions for treating diseases or disorders associated with oxidative stress and/or genomic instability. In particular, the invention relates to methods for treating ataxia-telangeictasia (AT) and such disease states by administering a therapeutically effective amount of a chelating agent to increase genomic stability and/or decrease oxidative stress.